In Pennsylvania, about 1,100 licensed pharmacies have shut down since early 2020, the biggest wave anyone remembers. These spots weren’t just pill dispensers, they gave vaccines, health tips, and quick checks in small towns and city blocks.
Patients drive farther, stress builds, and rural spots hurt most. The math is brutal as fewer stores mean bigger gaps in health access. Will new spots fill the void?
“Help” Law That’s Not Helping Yet
In 2024, politicians cheered Act 77 as a hero for squeezed local pharmacies battling pharmacy benefit managers (PBMs), those middlemen dictating drug deals. This bipartisan law promised stricter rules and shields. But doors kept closing.
By late 2025, Pennsylvania lost hundreds of pharmacies net since 2020. Owners say relief feels like a mirage. Many rules kick in only in 2026. Meanwhile, small shops fight to survive. It’s like promising a lifeboat after the ship sinks.
The Road to Pharmacy Closures
COVID flipped the script on pharmacies. In Pennsylvania, over 800 shut from 2020-2025, before a giant chain’s bankruptcy piled on. Nationally, it’s the same as customers saw soaring drug costs and puny reimbursements. New stores popped up, but not enough to balance the scales.
Independents, especially, can’t keep up. Imagine stocking shelves but losing money per pill. Owners slash hours or close. This hit small towns hard and it’s only widening health gaps.
Squeezed by Middlemen Power Plays
Blame the PBMs, the insurer middlemen who control drug payouts. Pharmacies often get paid less than what drugs cost them, forcing losses on every fill. Contracts hide details and gag price talks with patients. Margins vanish, so staff cuts, shorter hours, or shutters follow and rural and poor areas suffer most.
Owners feel trapped as it’s a squeeze from all sides with high costs, low pay, and lots of red tape. No wonder closures spike and patients pay the price.
Act 77’s Tough Wake-Up Call
Act 77 arrived in 2024 amid a closure storm, hailed as PBM-tamer to save shops. By November 2025, 1,100 stores have closed down since 2020 which leads to net hundreds lost.
Pharmacies hang on by a thread. Rural spots vanish fastest, leaving “deserts” in areas that need them the most. Owners hustle, but time’s short.
Rite Aid’s Massive Exit Shock
Rite Aid’s 2023-2025 bankruptcy rocked Pennsylvania, closing around 500 stores, nearly half of all 1,100 losses. These were neighborhood anchors which were gone overnight, leaving voids. Survivors, mostly independents, got slammed with new customers, with no extra help.
Neighborhoods lost easy access to medications and rural drives got longer. This quickly led to patients missing doses causing even more stress among people.
Patients Stuck Without Meds
Patients face real dangers when local pharmacies close in Pennsylvania, often going days without critical medications like blood pressure or mental health drugs. Closures force longer drives, unreliable mail-order options, and frantic calls to new providers, spiking stress and health risks for chronic conditions.
Elderly and low-income folks without cars suffer most, sometimes skipping doses entirely. Act 77 helps some insured plans, but 76% of residents fall outside, leaving gaps. Rationing meds becomes common leaving people stranded without medicine they desperately need.
Rural Areas Turning into Deserts
Since 2020, hundreds of pharmacies have closed statewide, with rural counties losing their sole local options, leaving 540,000 rural residents at least 5 miles from the nearest store as of recent data. Closures hit Sullivan and Cameron counties hardest, now with just one pharmacy each, forcing 20-40 mile drives that spike in bad weather.
Pennsylvania’s 2,964 licensed spots as of May 2025 can’t keep up. PBM pressures and costs drive this and rural hospitals closing too compounds isolation.
This Isn’t Just Pennsylvania’s Problem
Pharmacy closures aren’t unique to Pennsylvania, they’re creating deserts across America, leaving tens of millions far from meds and care. A 2025 University of Pittsburgh/NIH study estimates 57.1 million people, nearly 18% of the U.S. population, live in or near these zones, where travel barriers block access.
Rural South, Midwest, and urban poor areas suffer most, mirroring PA’s net hundreds lost since 2020. National mapping tools now flag 10+ mile rural drives as red alerts. Federal PBM reforms lag state efforts like Act 77, leaving gaps.
Law Misses Most Folks
Act 77 promised to shield Pennsylvania pharmacies from PBM abuses, but it covers just 24% of the insurance market, leaving 76% of residents, about 9.7 million people, fully exposed. This includes major employer plans, federal programs like Medicare, and out-of-state contracts the state can’t touch, per court rulings.
Patients in these gaps still face steering to PBM-affiliated chains, clawbacks, and opaque pricing, fueling closures despite the law.
Lawmakers Fire Up the Pressure
Lawmakers in Pennsylvania are ramping up pressure on the Shapiro administration over Act 77’s shaky rollout, demanding faster action to halt pharmacy closures amid PBM abuses. A bipartisan crew, four Democrats and two Republicans, fired off a July 1, 2025, letter to Insurance Commissioner Michael Humphreys, stating unsustainable reimbursement rates and weak enforcement in rural areas.
They followed with a September hearing and October letter from more senators, probing steering studies, appeals, and PBM interactions.
Who’s Enforcing the New Rules?
Pennsylvania Insurance Department now polices Act 77 by scanning PBM contracts, blocking steering, and grabbing transparency data. Pharmacists love the tools but slam timid rollout. Regulators say that rulemaking takes time amid lawsuits. Without bold moves on underpayments, closures continue. It’s cautious vs. urgent.
Big Gaps in the Law
Act 77 aimed to curb PBM abuses like spread pricing, where middlemen charge insurers more than they pay pharmacies, pocketing the spread but key gaps weaken it. A full ban on spread pricing was stripped from the final bill by the GOP-controlled Senate, leaving this lucrative practice intact despite draining billions from independents yearly.
Critics argue it starves rural shops, fueling the 1,100+ closures since 2020, while supporters call it a pragmatic compromise for future tweaks.
How Pharmacies Fight to Stay Open
Pennsylvania pharmacies are hustling to reinvent beyond PBM traps, pivoting to clinical services like immunizations, medication therapy management (MTM), home deliveries, and chronic disease coaching.
These add-ons generate 20-30% extra revenue for independents, offsetting erratic reimbursements and rising costs. Rural shops deliver to deserts, while urban ones offer point-of-care tests, turning liabilities into lifelines.
What’s Coming in 2026?
2026 marks a make-or-break year for Pennsylvania’s Act 77, with key protections finally kicking in to battle PBM abuses and pharmacy closures. Individual policies via Pennie or direct insurers gain shields starting January 2026, including anti-steering rules, clawback bans, and above-cost reimbursements for 90% of drugs.
Large employer plans phase in mid-2025 to 2026 as the first Network Adequacy Report drops April 1, and the Transparency Report by July 1, exposing rebates, fees, and networks.
Sources:
Spotlight PA – Pharmacy Closures Continue Despite New Law
WPSU – Impact of PA Pharmacy Closures in 3 Maps
ArcGIS StoryMap – Pharmacy Closures & Pharmacies at Risk
RescueMeds – PA Pharmacy Desert Crisis & PBM Reform
Supermarket News – PA’s Pharmacy Problem